Galderma Group AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	35,017	23,909	-	-	-
Enterprise Value	36,918	26,211	-	-	-
Last Close Price	147.50	100.47	-	-	-
PE Ratio	116.68	114.22	-	-	-
Forward PE	44.92	43.27	-	-	-
PS Ratio	9.39	5.94	-	-	-
PB Ratio	5.70	3.39	-	-	-
P/FCF Ratio	52.17	73.29	-	-	-
P/OCF Ratio	46.30	54.07	-	-	-
PEG Ratio	1.22	1.02	-	-	-
EV/Sales Ratio	9.90	6.52	-	-	-
EV/EBITDA Ratio	45.65	32.46	-	-	-
EV/EBIT Ratio	62.14	43.11	-	-	-
EV/FCF Ratio	55.00	80.35	-	-	-
Debt / Equity Ratio	0.37	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	2.80	3.00	5.83	8.68	9.67
Debt / FCF Ratio	3.37	7.66	111.57	583.27	39.02
Asset Turnover	0.37	0.35	0.33	0.31	-
Inventory Turnover	3.15	3.29	2.86	3.03	-
Quick Ratio	0.76	0.89	0.72	0.52	0.55
Current Ratio	1.09	1.21	1.03	0.77	0.82
Return on Equity (ROE)	4.92%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.67%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.41%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.70%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	0.86%	0.88%	-	-	-
FCF Yield	1.92%	1.36%	-	-	-
Dividend Yield	0.10%	0.15%	-	-	-
Buyback Yield / Dilution	95.82%	95.82%	-9.65%	-	-
Total Shareholder Return	95.92%	95.97%	-9.65%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.